Intrinsiqq
PharmaNutra S.p.A. logo

PharmaNutra S.p.A.

PHN.XMIL

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap€813M
EPS€2.16
P/E39.29
P/FCF50.78
EV/EBITDA22.87
FCF Yield2.0%
Div. Yield1.20%
Net Debt/FCF0.1x
PharmaNutra S.p.A. intrinsic value
52-Week Range
€50.00€94.00

Profitability & Returns

Revenue (TTM)

€140M

▲ +14.0% YoY

Net Income (TTM)

€21M

▲ +20.8% YoY

Op. Margin

22.62%

▼ -0.9pp YoY

ROIC

26.85%

▲ +2.7pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

€16M

▲ +1.1% YoY

Op. Cash Flow (TTM)

€18M

▲ +1.1% YoY

Net Debt

€2M

Cash & Equiv.

€19M

3Y CAGR: +16.4%

Continue Research

Peers

Drug Manufacturers - Specialty & Generic · Pick stocks to compare with PHN.XMIL

CompareIntrinsic value
TALEA.XMILTalea Group S.p.A.
No recent price33
COSMO.XMILFarmacosmo S.p.A.
€0.37+1.66%10
PMED.XMILPiu Medical S.p.A.
€5.45+4.81%25
PHIL.XMILPhilogen S.p.A.
€19.86-1.44%98
GHC.XMILGarofalo Health Care S.p.A.
€5.10-0.39%40
ELN.XMILEL.En. S.p.A.
€16.43-0.54%53
SFL.XMILSafilo Group S.p.A.
€2.18-5.05%69
ATRY.XMADAtrys Health, S.A.
€2.60-2.44%0

Held by ETFs

PHN.XMIL is in 3 US ETFs. The largest of them, with PHN.XMIL's weight in each:

PharmaNutra S.p.A. (PHN.XMIL) in four numbers

Fair value (earnings)
€69.98
Price €84.70 is 21% above it.
Intrinsic Value
Quality score
53/100
Best check: revenue growth, 13.7%. Weakest: margin trend, -5.0pp.
Quality
Dividend (TTM)
€1.00
1.20% yield, raised at least 5 years in a row.
Dividends
P/E
39.29
Price to free cash flow 50.78.
Financials

Questions about PharmaNutra S.p.A.

Is PharmaNutra S.p.A. (PHN.XMIL) overvalued?

At €84.70, PharmaNutra S.p.A.'s price is 21% above the €69.98 a share fair value that Intrinsiqq's calculator gets from its earnings. It trades at 39.29 times earnings and 50.78 times free cash flow. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.

What is PharmaNutra S.p.A.'s fair value?

Intrinsiqq's calculator puts PharmaNutra S.p.A.'s fair value at €69.98 a share. It grows earnings per share 10.1% a year for 5 years, applies an exit P/E of 30, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of €52.49. Every input can be changed on the Intrinsic Value tab.

Is PharmaNutra S.p.A. a high-quality business?

PharmaNutra S.p.A. scores 53 out of 100 on Intrinsiqq's quality score, which makes it a mixed business on these measures. The score blends 8 checks computed from company filings. Its best check is revenue growth at 13.7%, and its weakest is margin trend at -5.0pp. The Quality tab shows every check against its target.

Does PharmaNutra S.p.A. (PHN.XMIL) pay a dividend, and how much?

Yes. PharmaNutra S.p.A. (PHN.XMIL) pays a dividend: €1.00 per share over the last twelve months, a dividend yield of 1.20% at the latest close. It has raised its dividend per share for at least 5 years in a row, growing at 12.4% a year over the last 5 years. The payout takes about 46.5% of earnings.

Source: company filings. Price: last close 17 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing PHN.XMIL

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.